SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-000999
Filing Date
2023-01-05
Accepted
2023-01-05 16:30:58
Documents
1
Period of Report
2023-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10635
  Complete submission text file 0000899243-23-000999.txt   13642
Mailing Address 126 EAST 56TH STREET 20TH FLOOR NEW YORK NY 10022
Business Address
LAINOVIC SACHA (Reporting) CIK: 0001053891 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39112 | Film No.: 23511775

Mailing Address 202 CARNEGIE CENTER SUITE 106 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 106 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Issuer) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 126 EAST 56TH STREET, 20TH FLOOR NEW YORK NY 10022
Business Address 126 EAST 56TH STREET, 20TH FLOOR NEW YORK NY 10022 212-616-2555
InvOpps IV US, L.P. (Reporting) CIK: 0001745076 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39112 | Film No.: 23511776

Mailing Address 126 EAST 56TH STREET, 20THFLOOR NEW YORK NY 10022
Business Address 126 EAST 56TH STREET, 20THFLOOR NEW YORK NY 10022 212-616-2555
InvOpps GP IV, L.L.C. (Reporting) CIK: 0001792570 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39112 | Film No.: 23511778

Mailing Address 126 EAST 56TH STREET, 20THFLOOR NEW YORK NY 10022
Business Address 126 EAST 56TH STREET, 20THFLOOR NEW YORK NY 10022 212-616-2555
InvOpps IV, L.P. (Reporting) CIK: 0001792575 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39112 | Film No.: 23511777